BridgeBio Pharma EPS - Earnings per Share 2018-2024 | BBIO

BridgeBio Pharma earnings per share (EPS) for the twelve months ending September 30, 2024 was $-2.42, a 37.79% decline year-over-year.

  • BridgeBio Pharma EPS for the quarter ending September 30, 2024 was $-0.86, a 20.37% decline year-over-year.
  • BridgeBio Pharma 2023 annual EPS was $-3.95, a 21.17% increase from 2022.
  • BridgeBio Pharma 2022 annual EPS was $-3.26, a 16.41% decline from 2021.
  • BridgeBio Pharma 2021 annual EPS was $-3.9, a 2.63% increase from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

BridgeBio Pharma EPS - Earnings per Share 2018-2024 | BBIO

  • BridgeBio Pharma EPS for the quarter ending September 30, 2024 was $-0.86, a 20.37% decline year-over-year.
  • BridgeBio Pharma 2023 annual EPS was $-3.95, a 21.17% increase from 2022.
  • BridgeBio Pharma 2022 annual EPS was $-3.26, a 16.41% decline from 2021.
  • BridgeBio Pharma 2021 annual EPS was $-3.9, a 2.63% increase from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Teva Pharmaceutical Industries (TEVA)$24.9B
Dr Reddy's Laboratories (RDY)$12.6B
Bausch Health Cos (BHC)$2.8B
Supernus Pharmaceuticals (SUPN)$2.1B
Amphastar Pharmaceuticals (AMPH)$1.7B
Personalis (PSNL)$396M
Taysha Gene Therapies (TSHA)$314M
Assembly Biosciences (ASMB)$95M
Sol-Gel Technologies (SLGL)$25M
Evoke Pharma (EVOK)$6M
Teligent (TLGT)$0M